MKI67 and neoplasm: Clinical factors and conventional imaging often poorly predict this aggressive feature, while immunohistochemistry can explore the nature of tumor growth and invasiveness by detecting the expression of certain biomarkers, such as Ki67, which reflects cell proliferation (4).